Tharimmune, Inc. 8-K

What Happened
Tharimmune, Inc. (THAR) announced on January 26, 2026 (via an 8-K under Item 8.01) that the company will serve as a Super Validator on the Canton network. The company attached a press release describing the announcement as Exhibit 99.1 to the filing.

Key Details

• Announcement date: January 26, 2026 (8-K filed same day, Item 8.01).
• Role: Tharimmune named as a "Super Validator" on the Canton network.
• Disclosure: Press release describing the role is attached as Exhibit 99.1 to the 8-K.
• Financial impact: The filing does not disclose any financial results, revenue, or specific monetary terms related to the validator role.

Why It Matters
This 8-K informs investors that Tharimmune is publicly positioning itself in blockchain validation activities via the Canton network. While the filing confirms the strategic development, it does not provide financial details or projections, so investors should treat this as a business update rather than evidence of immediate revenue or earnings impact. Investors seeking material financial implications should look for future disclosures or company commentary with specific terms or results.